2021 ACR/VF GCA/TAK Guidelines - Vasculitis Foundation
Vascular Disease Patient Information Page: Giant cell (temporal) arteritis - Samip Sheth, Alexandra Solomon, Brendan Antiochos, Natalie Evans, Elizabeth V Ratchford, 2022
Giant cell arteritis
The Diagnosis and Treatment of Giant Cell Arteritis (24.05.2013)
Giant cell/temporal arteritis | acute-gp
Efficacy and Safety of Tocilizumab in Patients with Giant Cell Arteritis: Primary and Secondary Outcomes from a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial - ACR Meeting Abstracts
Current advancements in the management of giant cell arteritis | Aging Health
Giant cell arteritis (GCA) | Causes, symptoms, treatments
Treatment of giant cell arteritis - ScienceDirect
Cureus | Giant Cell Arteritis and Cardiac Comorbidity | Article
2021 ACR/VF GCA/TAK Guidelines - Vasculitis Foundation
2018 Update of the EULAR recommendations for the management of large vessel vasculitis
Article: Extracranial giant cell arteritis: A narrative review (full text) - June 2016 - NJM
Tocilizumab plus prednisone reduces treatment failure risk sixfold in giant cell arteritis
JCM | Free Full-Text | Temporal Artery Vascular Diseases
Monitoring and long-term management of giant cell arteritis and polymyalgia rheumatica | Nature Reviews Rheumatology
Diagnosis and management of giant cell arteritis
Treatment of giant cell arteritis - ScienceDirect
Frontiers | The Treatment of Giant Cell Arteritis in Different Clinical Settings
Temporal Arteritis | Symptoms, Signs, Management | Geeky Medics
Giant cell arteritis
Giant Cell Arteritis: An Update on Diagnosis and Management
JCM | Free Full-Text | Treatment of Giant Cell Arteritis (GCA)
Suggested Treatment Algorithms for the Management of ... | GrepMed
